Latest Global Lenograstim RFP & RFQ

Completion of a Non -Exclusive Discount Agreement According to Section 130A (8) Sgb V on the Active Ingredient Lenograstim, Atc L03aa10 for the Time 01.11.2025 - 31.10.2027

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Lenograstim (Atc Code: L03aa10).

Drugs Medicinal 9 Lots: Lot # 1 Pegfilgrastim Lot №2 Albumin Lot №3 Enalapril Lot №4 Infliximab Lot №5 -lenograstim Lot №6 Comb Drug Lot № 7 - Comb Drug Lot №8 - Mycophenolic

Tender for the Supply of Lenograstim Injection 13Miu/Ml

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Lenograstim (L03aa10) as Part of a So-Calle...

Supply of Lenograstim 33.6 Mui Syringe, Lenvatinib 10 Mg Capsules, Lenvatinib 4 Mg Capsules

Supply of Lenalidomide 25 Mg Capsules, Lenalidomide 5 Mg Capsules, Lenograstim 263 Mcg Vials

Oh-Biologika-2023-28 - Lenograstim

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Lenograstim, Atc L03aa10 for the Period November 1St, 2023 - October 31St, 2025

Code Dc 021:2015 - 33600000-6 Pharmaceutical Products. Lenograstim, Lyophilisate for Solution for Injection, 33.6 Million Iu (263 Μg) Per 1 Ml, Amp., Fl., Spr.